18 results with keyword: 'anti vascular endothelial growth factor proliferative diabetic retinopathy'
VEGF: vascular endothelial growth factor; DR: diabetic retinopathy; DME: diabetic macular edema; NPDR: non-proliferative diabetic retinopathy; PDR: proliferative diabetic
N/A
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd... the median control group risk across studies) is provided in footnotes.. The corresponding
N/A
injections for the prevention of post-vitrectomy complications in proliferative diabetic retinopathy (PDR) patients with elevated vitreous vascular endothelial growth factor
N/A
During both physio- logical retinal vascular development (1) and pathological proliferative retinopathy (2), new blood vessel growth is regulated by vascular endothelial growth
N/A
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group
N/A
The first goal of this paper was to determine whether chronic exposure to mild decreased oxygen (15% O 2 ) induces the HIF signaling system in blood vessels. The sec- ond goal was
N/A
DR, diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy; OIR, oxygen-induced retinopathy; PDR, proliferative diabetic retinopathy; STZ, streptozotocin; VEGF,
N/A
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.. Aiello LP and
N/A
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.. Aiello LP and
N/A
Purpose: To investigate the effect of bevacizumab (Avastin; Genentech, San Francis- co, CA, USA) on vascular endothelial growth factor (VEGF) expression and inflam- mation
N/A
The VEGF-A/PDGF-AB concentration ratios in both vitreous and serum samples were not signi fi cantly higher in the diabetic patients compared with those in the control group ( Table 3
N/A
Keywords: vascular endothelial growth factor, retinopathy of prematurity, intravitreal neovas- cularization, oxygen-induced retinopathy model, physiological retinal
N/A
Bevacizumab; Vascular Endothelial Growth Factor; Panretinal Photocoagulation; Diabetic Retinopathy ©2017, Med Hypothesis Discov Innov Ophthalmol.. This is an open-access article
N/A
Vascular endothelial growth factor (VEGF)-related single nucleo- tide polymorphisms rs10738760 and rs6921438 are not associated with diabetic retinopathy (DR) in Slovenian
N/A
Relationship of vascular endothelial growth factor (VEGF) + 405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes. Bleda S, De Haro J, Varela
N/A
In this study, we also compared serum and vitreous vascular endothelial growth factor (VEGF) levels and stages of nephropathy, ie, mild (nonspecific light micros- copy changes
N/A
Purpose: To report the 24-month anatomic and Early Treatment Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (BCVA) response after primary intravitreal
N/A
Association of polymorphisms in the vascular endothelial growth factor gene and its serum levels with diabetic retinopathy in Chinese patients with type 2 diabetes: a
N/A